Damora Therapeutics (DMRA) News
NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
23.22-1.08 (-4.44%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DMRA news summary
We found 2 recent headlines mentioning Damora Therapeutics (DMRA): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, GlobeNewswire. For price context, DMRA is down 4.44% at $23.22. The most recent story, "Damora Therapeutics GAAP EPS of -$0.40 beats by $0.07", was published by Seeking Alpha on Nov 4, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Damora Therapeutics headlines
- Damora Therapeutics GAAP EPS of -$0.40 beats by $0.07Seeking Alpha
- Damora Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights-- CLARITY-101 Phase 1/1b clinical trial initiated and cleared by multiple global regulatory authorities, including the U.S. Food and Drug Administration (FDA) -- -- New preclinical data highlighting…GlobeNewswire